Products for Research Use Only
RegisterLogin

Bivatuzumab

CAT: 0804-HY-P99281-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99281-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Bivatuzumab (Anti-CD44 Recombinant Antibody; BIWA 4) is a humanized monoclonal antibody directed against CD44v6. CD44v6 could acts as a sarcoma target for CAR-redirected CIK cells[1].
CAS Number
214559-60-1
Product Name Alternative
BIWA 4; Anti-CD44 Recombinant Antibody
UNSPSC
12352203
Target
Others
Type
Inhibitory Antibodies
Related Pathways
Others
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bivatuzumab.html
Purity
99.82
Solubility
10 mM in DMSO
Smiles
[Bivatuzumab]
Molecular Weight
(143.22 kDa)
References & Citations
[1]Leuci V, et al. CD44v6 as innovative sarcoma target for CAR-redirected CIK cells. Oncoimmunology. 2018 Feb 15;7 (5) :e1423167.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 1

Alternative Products

CatalogName
T77480-01Bivatuzumab
GTR18333588-01Bivatuzumab Antibody
C00347-1mg*25Bivatuzumab (Anti-CD44v6)
HB183016-01Research Grade Bivatuzumab
048282CD44v6 (bivatuzumab) discontinued
591715Bivatuzumab (CD44, CD44V)
KBI1195KRIBIOLISA™ Bivatuzumab ELISA
E55B0345Bivatuzumab (Reference antibody)
F1494-50Anti-CD44v6 Antibody (Bivatuzumab)
ABS-224-100ugBivatuzumab Biosimilar, Research Grade

Popular Products